Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer have?
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer has 10,184 citations in the OpenAlex counts ScholarIQ stores.
When was Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer published?
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer has 2016 year in the ScholarIQ index.
What is the open-access status of Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer?
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer?
The DOI for Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer?
The PMID for Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer?
The OpenAlex for Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer is on the source record.